Tiny heart plug aims to stop killer strokes
NCT ID NCT03616028
Summary
This early study is testing a new heart implant called the CLAAS device. It is designed for people with atrial fibrillation (AFib) who are at high risk of stroke but cannot take long-term blood thinners. The device is placed to seal off a small pouch in the heart where dangerous blood clots often form, aiming to prevent strokes without needing daily medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON VALVULAR ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott & white Research Institute
Plano, Texas, 75093, United States
-
Catholic Medical Center
Manchester, New Hampshire, 03102, United States
-
Columbia University Medical Center/NYPH
New York, New York, 10032, United States
-
Erlanger Health System
Chattanooga, Tennessee, 37403, United States
-
Lankenau Heart Institute
Wynnewood, Pennsylvania, 19096, United States
-
Mount Sinai
New York, New York, 10029, United States
-
Pacific Heart Institute
Santa Monica, California, 90404, United States
-
St. Bernards Medical Center
Jonesboro, Arkansas, 72401, United States
-
Texas Cardiac Arrhythmia Institute
Austin, Texas, 78705, United States
-
The Christ Hospital
Cincinnati, Ohio, 45219, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.